A synthetic antioxidant developed by researchers at National Jewish Medical and Research Center improves the survival of islet cells used in transplants for diabetes. The findings, reported in the August issue of the journal Diabetes by researchers at the University of Pittsburgh, could help overcome a significant drawback of the "Edmonton Protocol," a promising treatment for diabetes.
"The antioxidant neutralizes the harmful free radicals generated when islet cells are isolated from the pancreas," said senior author Jon Piganelli, Ph.D., assistant professor of Pediatrics at the Diabetes Institute, Childrens Hospital of Pittsburgh, and the University of Pittsburgh School of Medicine. "More of the islet cells survived in culture. And when we transplanted islet cells into diabetic, immunodeficient mice, it took fewer of the antioxidant-treated islet cells to normalize their blood sugar."
In type 1 diabetes, a persons immune system mistakenly attacks and destroys islet cells that secrete insulin necessary for the metabolism of sugar. Many diabetes patients take insulin shots to make up for the lost islet cells. In 2000, researchers from Edmonton, Alberta, reported new techniques that have made islet-cell transplantation a promising option for patients with type 1 diabetes. It allows patients to produce their own insulin. Patients have to take immunosuppressive drugs to prevent rejection of the transplants, but they maintain better control of their insulin levels, thus reducing the chances of future complications. They also avoid the daily insulin injections. Clinical trials of the "Edmonton protocol" are being conducted at several medical centers around the nation.
One drawback to the Edmonton protocol is that pancreata from at least two donors are needed to supply enough islet cells for one successful transplant. Many cells die during isolation and shortly after transplantation. Since islet cells also rapidly die in culture, surgeons are forced to transplant the cells immediately after they have been isolated. This prevents physicians from taking several steps that could improve the likelihood of a successful transplant. Isolation of the islet cells from the pancreas stresses them, leading to inflammation and islet-cell death. Highly reactive free-radical molecules contribute to this stress. Dr. Piganelli and his colleagues reasoned that an antioxidant compound might help islet cells survive and improve transplant success by neutralizing the free radicals.
The researchers used two synthetic antioxidants developed several years earlier by Dr. James Crapo, M.D., Chairman of the Department of Medicine at National Jewish, and his colleagues. The antioxidants, dubbed AEOL10113 and AEOL10150, mimic the naturally occurring antioxidant superoxide dismutase, but are effective against a wider range of oxygen radicals and last longer in the body. Now licensed by Incara Pharmaceuticals Corporation, they have shown promise in preventing damage to cells caused by stroke and radiation therapy for cancer. Earlier this year, Dr. Piganelli and his colleagues showed that the antioxidants could prevent the development of type 1 diabetes in mice when given T cells that normally causes the disease. (Press release)
"We are excited that these synthetic antioxidants are protecting cells in such a wide range of hazardous conditions," said Dr. Crapo.
Islet-cell loss was cut in half over a six-day period, from 60% to 30%, when the antioxidants were applied during isolation of the islet cells. The antioxidants also improved the effectiveness of the islet-cell transplants. When large amounts of islet cells (700-1,000 islet equivalents) were transplanted into six diabetic mice, all the animals became healthy. But when smaller amounts of islet cells (200-220 islet equivalents) were transplanted into nine diabetic mice, half the mice who got untreated islet cells remained diabetic while all the animals with antioxidant-treated islet cells returned to full health.
"The antioxidant-treated cells are healthier when they are transplanted into the mice and survive better after the transplant," said Dr. Piganelli. "We think it may be worthwhile to use the antioxidant during preservation of the pancreas, before the isolation begins, and after transplantation."
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.
In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
24.05.2017 | Physics and Astronomy
24.05.2017 | Physics and Astronomy
24.05.2017 | Event News